Tag: Selinexor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Selinexor

Real World Velcade Data in Newly Diagnosed Myeloma - HealthTree Foundation

Added to Collection on: 2024-01-18 19:41:50

Tags for this article:

Orphan drugs
Pyrazines
Multiple myeloma
Bortezomib
Antineoplastic drugs
Takeda Oncology
Selinexor
Velcade

Click the tags to see associated articles and topics

View Article Details
New hope for GSK's once potential ADC blockbuster Blenrep - Clinical Trials Arena

Added to Collection on: 2024-02-08 21:52:20

Tags for this article:

Orphan drugs
Multiple myeloma
Daratumumab
Pomalidomide
Belantamab mafodotin
Antibody-drug conjugate
Dexamethasone
Cereblon E3 ligase modulator
Lenalidomide
Bortezomib
Daratumumab/hyaluronidase
Selinexor
Velcade

Click the tags to see associated articles and topics

View Article Details
Multiple Myeloma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024

Added to Collection on: 2024-02-21 22:57:36

Tags for this article:

Orphan drugs
Multiple myeloma
Pomalidomide
Isatuximab
Selinexor
Daratumumab
Bortezomib
Carfilzomib
CASI Pharmaceuticals
AbbVie
Lenalidomide
Takeda Oncology

Click the tags to see associated articles and topics

View Article Details
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments

Added to Collection on: 2024-06-21 22:47:30

Tags for this article:

Orphan drugs
Isatuximab
Multiple myeloma
Pomalidomide
Daratumumab
Lenalidomide
Dexamethasone
Bortezomib
Selinexor
Elotuzumab

Click the tags to see associated articles and topics

View Article Details
FDA Approves Isatuximab With Bortezomib, Lenalidomide, and Dexamethasone for NDMM

Added to Collection on: 2024-09-20 22:20:25

Tags for this article:

Orphan drugs
Isatuximab
Multiple myeloma
Lenalidomide
Bortezomib
Cereblon E3 ligase modulator
Dexamethasone
Progression-free survival
Selinexor
Daratumumab/hyaluronidase

Click the tags to see associated articles and topics

View Article Details
Lenalidomide-Obinutuzumab Combo Yields Promising Results in Relapsed NHL

Added to Collection on: 2024-09-21 20:27:49

Tags for this article:

Orphan drugs
Lenalidomide
Obinutuzumab
Rituximab
Cereblon E3 ligase modulator
Indolent lymphoma
Lymphoma
Hodgkin lymphoma
Chronic lymphocytic leukemia
Carfilzomib
Selinexor

Click the tags to see associated articles and topics

View Article Details
Tafasitamab Plus Lenalidomide/Rituximab Improves PFS in Relapsed/Refractory Follicular ...

Added to Collection on: 2024-12-10 22:48:23

Tags for this article:

Orphan drugs
Non-Hodgkin lymphoma
Lymphoma
Antineoplastic drugs
Rituximab
Tafasitamab
Lenalidomide
Marginal zone lymphoma
Selinexor
Phosphoinositide 3-kinase inhibitor
Laurie H. Sehn

Click the tags to see associated articles and topics

View Article Details
Thrombocytopenia Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials ...

Added to Collection on: 2025-02-17 23:14:45

Tags for this article:

Orphan drugs
Rare diseases
Thrombopoietin receptor agonists
Fostamatinib
Organophosphates
Thrombocytopenia
Immune thrombocytopenic purpura
Eltrombopag
Danaparoid
Selinexor
Romiplostim
Thrombocytopenic purpura
Novartis
Rigel Pharmaceuticals
United States

Click the tags to see associated articles and topics

View Article Details
Treatment Line Trends In The European Multiple Myeloma Therapeutics Market

Added to Collection on: 2025-05-13 10:37:09

Tags for this article:

Orphan drugs
Isatuximab
Multiple myeloma
Selinexor
Daratumumab
Carfilzomib
Lenalidomide
Elotuzumab
Pomalidomide
Proteasome inhibitor
Bortezomib
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
Roche provides update on FDA Advisory Committee meeting on Columvi combination for ...

Added to Collection on: 2025-05-20 19:02:11

Tags for this article:

Lymphoma
Orphan drugs
Non-Hodgkin lymphoma
Antineoplastic drugs
Diffuse large B-cell lymphoma
Cancer treatments
Selinexor
Umbralisib

Click the tags to see associated articles and topics

View Article Details
Book a Demo